malcontented 发表于 2025-3-21 16:55:48

        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/if/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)影响因子@(眼科学)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=1080B7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)总引论文<br>        http://impactfactor.cn/2024/at/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)总引论文@(眼科学)学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=1080B7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/2024/tc/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)总引频次@(眼科学)学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=1080B7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)即时影响因子<br>        http://impactfactor.cn/2024/ii/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)即时影响因子@(眼科学)学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=1080B7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)五年累积影响因子<br>        http://impactfactor.cn/2024/5y/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)五年累积影响因子@(眼科学)学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=1080B7683<br><br>       

MAUVE 发表于 2025-3-21 20:27:48

http://reply.papertrans.cn/2/185/18439/18439-2.png

ATP861 发表于 2025-3-22 03:17:09

http://reply.papertrans.cn/2/185/18439/18439-3.png

符合你规定 发表于 2025-3-22 07:26:49

Submitted on: 18 October 2003.
Revised on: 01 January 2004.
Accepted on: 21 January 2004.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Myofibrils 发表于 2025-3-22 11:14:03

Submitted on: 07 December 2014.
Revised on: 30 December 2014.
Accepted on: 08 February 2015.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Dislocation 发表于 2025-3-22 13:11:22

Submitted on: 05 July 2008.
Revised on: 04 September 2008.
Accepted on: 20 October 2008.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

excrete 发表于 2025-3-22 19:03:29

Submitted on: 19 November 2001.
Revised on: 25 February 2002.
Accepted on: 24 March 2002.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

彩色 发表于 2025-3-22 22:56:58

Submitted on: 06 April 2004.
Revised on: 02 July 2004.
Accepted on: 03 August 2004.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

OASIS 发表于 2025-3-23 04:58:11

http://reply.papertrans.cn/2/185/18439/18439-9.png

AXIOM 发表于 2025-3-23 05:42:09

Submitted on: 07 November 2016.
Revised on: 22 January 2017.
Accepted on: 04 March 2017.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
页: [1] 2 3 4
查看完整版本: SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (OPHTHALMO